ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting

by Thomas R. Collins • April 11, 2016

  • Tweet
  • Email
Print-Friendly Version

MIAMI BEACH—Managing head and neck cancer involves high-stakes decisions that are full of nuance, with a need to weigh factors that range from a patient’s history to co-morbidities to tumor grade and location. Through the presentation of two clinical scenarios, a panel of experts dug into the details of case management of head and neck carcinoma during the Triological Society Combined Sections Meeting, held January 22–24 in Miami Beach, Fla.

You Might Also Like

  • Otolaryngologists Gather for 2016 TRIO Combined Sections Meeting
  • Researchers Present Findings at 2016 TRIO Combined Sections Meeting
  • PET-Directed Management of Node-Positive Head and Neck Cancers
  • Triological Society Presents Otolaryngology Awards at 2014 Combined Sections Meeting
Explore This Issue
April 2016

Case 1: Left Parotid Tail Mass

A 38-year-old white female with a new-onset, 2-cm, left parotid tail mass has a history of Hodgkin’s lymphoma, for which she has undergone five courses of R-CHOP chemotherapy.

Francisco Civantos, MD, co-director of the division of head and neck surgery/otolaryngology at the University of Miami’s Sylvester Comprehensive Cancer Center in Florida, asked whether there was anything remarkable in her clinical exam. Panel moderator and case presenter Dennis Kraus, MD, director of the Center for Head and Neck Oncology at the New York Head and Neck Institute, said the patient reported that she generally felt pretty well.

Prior treatment of the head and neck might influence the effectiveness of future postoperative radiation.

Prior treatment of the head and neck might influence the effectiveness of future postoperative radiation.
m.jrn/shutterstock.com

Richard Smith, MD, professor and vice chair of otorhinolaryngology-head and neck surgery and professor of pathology at Albert Einstein College of Medicine in New York City, said that recurrent lymphoma was possible. But Dr. Kraus said there were no obvious signs of that; on MRI, for instance, the mass appeared to be isolated, without infiltrating surrounding tissue. The mass was removed, Dr. Kraus said, and pathology found that the mass was a low-grade acinic cell carcinoma.

Maie St. John, MD, PhD, chair of head and neck surgery at the University of California, Los Angeles, and co-director of the UCLA Head and Neck Cancer, said the best course would probably be no further treatment. “At this point, if it’s well-encapsulated and low-grade, I would not offer neck dissection, but I would offer close surveillance,” she said. If there were no aggressive features, she would not offer postoperative radiation, she added.

Jonas Johnson, MD, professor and chair of the department of otolaryngology at the University of Pittsburgh School of Medicine, noted the importance of considering how close the mass is to the facial nerve, but Dr. Kraus said that was not a concern, given what was seen during surgery.

Ultimately, the tumor board opted for no more treatment. But high-grade acinic cell carcinomas might need a different response, Dr. Kraus said. “If you look at the literature for acinic cell, there is some controversy about our ability to grade them, although there’s clearly a distinction between low- and high-grade tumors,” he added. “There are reported cases, particularly in the higher grades, that some of these patients can develop metastatic disease.”

Case 2: Neck Node

A 68-year-old Hispanic male who, three years prior, received chemoradiation therapy for a T3N0 thoracic esophageal squamous cell carcinoma, now presents with a 3.5-cm left level 2 neck node. A needle biopsy, the pathologist determines, is HPV-negative metastatic squamous cell carcinoma that is negative for the p16(INK4a) tumor suppressor protein.

Pages: 1 2 3 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: head and neck cancer, Sections Meeting 2016, Triological SocietyIssue: April 2016

You Might Also Like:

  • Otolaryngologists Gather for 2016 TRIO Combined Sections Meeting
  • Researchers Present Findings at 2016 TRIO Combined Sections Meeting
  • PET-Directed Management of Node-Positive Head and Neck Cancers
  • Triological Society Presents Otolaryngology Awards at 2014 Combined Sections Meeting

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.